Article
ERK5 signalling in prostate cancer promotes an invasive phenotype.
British journal of cancer - 15 Feb 2011
Ramsay A K, McCracken S R C, Soofi M, Fleming J, Yu A X, Ahmad I, Morland R, Machesky L, Nixon C, Edwards D R, Nuttall R K, Seywright M, Marquez R, Keller E, Leung H Y
Abstract excerpt
BACKGROUND: Aberrant mitogen/extracellular signal-regulated kinase 5 (MEK5)-extracellular signal-regulated protein kinase 5 (ERK5)-mediated signalling has been implicated in a number of tumour types including prostate cancer (PCa). The molecular basis of ERK5-driven carcinogenesis and its clinical relevance remain to be fully characterised. METHODS: Modulation of ERK5 expression or function in human PCa PC3 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
